Evgeniya Ostroumova

Dr. Evgeniya Ostroumova

International Agency of Cancer Research (IARC), France

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2019 in Cancers
Verified
Journal Article
Open access
PDF file
LZLjubica Zupunski
Ljubica Zupunski
Evgeniya OstroumovaEvgeniya Ostroumova
Evgeniya Ostroumova
VDVladimir Drozdovitch
Vladimir Drozdovitch
IVIlya Veyalkin
Ilya Veyalkin
VIViktor Ivanov
Viktor Ivanov
AKAusrele Kesminiene
Ausrele Kesminiene
In this study, we expanded on a previously published population-based case-control study on subjects exposed to iodine-131 (131I) from Chernobyl fallout at age ≤18 years using improved individual 131I absorbed thyroid doses. We further studied the impact of iodine deficiency and other selected host risk factors on 131I-related thyroid cancer risk after childhood exposure. We included 298 thyroid cancer cases and 1934 matched controls from the most contaminated regions of Belarus and the Russian Federation. We performed statistical analysis using conditional logistic regression models. We found a statistically significant linear quadratic dose-effect association between thyroid cancer and 131I thyroid dose in the range up to 5 grays (Gy). Self-reported personal history of benign nodules, any thyroid disease except thyroid cancer, family history of thyroid cancer, increased body mass index, and deficient stable iodine status at the time of the accident were statistically significant risk factors (p < 0.05 for each factor) for thyroid cancer after adjustment for thyroid 131I dose effect. Subjects who received stable iodine supplementation in the years after the accident had a significantly lower 131I-related risk of thyroid cancer. Our findings are important for thyroid cancer prevention, and for further improvement of medical surveillance in the affected populations.


18 March 2020 in The Lancet
Verified
Journal Article
Closed access
Evgeniya OstroumovaEvgeniya Ostroumova
Evgeniya Ostroumova
JSJoachim Schüz
Joachim Schüz
AKAusrele Kesminiene
Ausrele Kesminiene

25 July 2020 in medRxiv
Verified
Preprint
Open access
PDF file
TTTherese Truong
Therese Truong
FLFabienne Lesueur
Fabienne Lesueur
PSPierre-Emmanuel Sugier
Pierre-Emmanuel Sugier
JGJulie Guibon
Julie Guibon
CXConstance Xhaard
Constance Xhaard
FVFlorent De Vathaire
Florent De Vathaire
Incidence of differentiated thyroid carcinoma (DTC) varies considerably between ethnic groups, with particularly high incidence rates in Pacific Islanders. Here, we conducted a genome-wide association study (GWAS) involving 1,554 cases/1,973 controls of European ancestry and 301 cases/348 controls of Oceanian ancestry from the EPITHYR consortium. Our results confirmed the association with the known DTC susceptibility loci at 2q35, 8p12, 9q22.33 and 14q13.3 in the European ancestry population and suggested two novel signals at 1p31.3 (rs334729) and 16q23.2 (rs16950982), which were associated with TSH levels in previous GWAS. We additionally replicated an association with 5p15.33 reported previously in Chinese and European populations. Except at 1p31.3, all associations were in the same direction in the population of Oceanian ancestry. The frequencies of risk alleles at 2q35, 5p15.33 and 16q23.2 were significantly higher in Oceanians than in Europeans and may explain part of the highest DTC incidence observed in Oceanians.